..The new biotech initiative whose board includes former Apple CEO John Sculley, ex-FDA commissioner Andrew Von Eschenbach and founder of Alphabet’s venture capital arm Bill Maris, is built around the idea that stem cells found in postpartum human placentas are ideal for regenerating damaged and aged tissue
3D Bioprinting BioBots Wants Piece of $50 Billion Pharmaceutical Industry Research Spend
..“We see 3D Bioprinting as a means to construct tissues and organs using regenerative and stem cells
https://www.forbes.com/sites/tjmccue/2015/03/11/3d-bioprinting-biobots-wants-piece-of-50-billion-pharmaceutical-industry-research-spend/#66493a4f561d The Global Stem Cells Group is a stand out from many companies in the stem cell medicine arena in that we focus on serving our clients by delivering the most relevant cutting edge solutions. We are committed to balancing competitive pricing and providing solid economic gains for our shareholders. By providing the best cellular medicine services available, we believe that we are building a company that will create more value for our customers and our stockholders. We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.